Pfizer launches Duchenne gene therapy study, joining Sarepta and Solid
April 12, 2018 at 12:10 PM EDT
All three companies are developing drugs made up of a shortened version of the dystrophin gene, which normally protects muscle cells but is absent in boys with Duchenne.